Beta Bionics, Inc.
BBNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $867 | $632 | $376 | $1,024 |
| - Cash | $38 | $35 | $42 | $30 |
| + Debt | $8 | $7 | $7 | $7 |
| Enterprise Value | $836 | $603 | $340 | $1,001 |
| Revenue | $27 | $23 | $18 | $20 |
| % Growth | 17.3% | 31.7% | -13.7% | – |
| Gross Profit | $15 | $13 | $9 | $12 |
| % Margin | 55.5% | 53.8% | 50.9% | 57.2% |
| EBITDA | -$14 | -$16 | -$18 | -$18 |
| % Margin | -49.6% | -69.8% | -102.3% | -86% |
| Net Income | -$14 | -$17 | -$29 | -$18 |
| % Margin | -52.1% | -72.6% | -162.5% | -88.6% |
| EPS Diluted | -0.33 | -0.39 | -0.93 | -0.42 |
| % Growth | 15.4% | 58.1% | -121.4% | – |
| Operating Cash Flow | -$9 | -$14 | -$20 | -$14 |
| Capital Expenditures | -$1 | -$2 | -$0 | -$1 |
| Free Cash Flow | -$10 | -$15 | -$20 | -$15 |